Anal HPV Surveillance — SCE Infectious Diseases MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Annual digital anorectal examination and anal cytology; consider high-resolution anoscopy referral if cytology becomes abnormal
HPV 16 positivity in an HIV-positive MSM, even with normal cytology, warrants annual surveillance because: (1) progression from normal to AIN2/3 occurs at a higher rate in PLWH than the general population, (2) cytology can miss early lesions (sensitivity ~50–70%), and (3) the ANCHOR trial demonstrated benefit of treating AIN2/3 when detected. BHIVA recommends annual digital anorectal examination (DARE) and annual anal cytology for MSM with HIV. If cytology becomes abnormal (ASC-US or worse), referral for high-resolution anoscopy (HRA) is indicated.
Reference: BHIVA 2022 – Anal cancer screening; ANCHOR Trial 2022